Stevanato Group (NYSE:STVN) Director Luciano Santel Sells 2,023 Shares of Stock

Stevanato Group S.p.A. (NYSE:STVN) Director Luciano Santel sold 2,023 shares of the firm’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of €20.09, for a total transaction of €40,642.07. Following the sale, the director owned 4,739 shares in the company, valued at approximately €95,206.51. The trade was a 29.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Stevanato Group Stock Up 1.9%

NYSE STVN traded up €0.38 on Monday, reaching €20.65. The company had a trading volume of 501,629 shares, compared to its average volume of 541,629. The company’s fifty day moving average is €18.80 and its 200-day moving average is €16.97. The firm has a market capitalization of $6.25 billion, a price-to-earnings ratio of 36.87, a price-to-earnings-growth ratio of 1.70 and a beta of 0.77. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.08 and a current ratio of 1.61. Stevanato Group S.p.A. has a 1-year low of €12.89 and a 1-year high of €28.00.

Stevanato Group (NYSE:STVN) last issued its quarterly earnings results on Friday, May 8th. The company reported €0.11 EPS for the quarter, missing analysts’ consensus estimates of €0.12 by (€0.01). The firm had revenue of €273.57 million during the quarter. Stevanato Group had a net margin of 10.99% and a return on equity of 10.43%. Stevanato Group’s quarterly revenue was up 6.6% on a year-over-year basis. During the same quarter last year, the business posted $0.10 EPS. On average, research analysts forecast that Stevanato Group S.p.A. will post 0.68 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Conestoga Capital Advisors LLC raised its holdings in shares of Stevanato Group by 7.6% in the 1st quarter. Conestoga Capital Advisors LLC now owns 8,491,751 shares of the company’s stock valued at $116,762,000 after purchasing an additional 602,050 shares during the period. T. Rowe Price Investment Management Inc. grew its holdings in Stevanato Group by 10.4% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 3,923,632 shares of the company’s stock worth $78,944,000 after purchasing an additional 368,792 shares during the period. TimesSquare Capital Management LLC increased its position in Stevanato Group by 7.1% during the fourth quarter. TimesSquare Capital Management LLC now owns 3,500,321 shares of the company’s stock worth $70,426,000 after buying an additional 232,645 shares during the last quarter. Bamco Inc. NY raised its stake in Stevanato Group by 1.4% in the fourth quarter. Bamco Inc. NY now owns 2,001,724 shares of the company’s stock valued at $40,275,000 after buying an additional 27,965 shares during the period. Finally, Jennison Associates LLC raised its stake in Stevanato Group by 13.7% in the fourth quarter. Jennison Associates LLC now owns 1,772,896 shares of the company’s stock valued at $35,671,000 after buying an additional 213,602 shares during the period.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. Weiss Ratings upgraded Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, July 16th. TD Cowen upgraded shares of Stevanato Group to a “strong-buy” rating in a report on Wednesday, June 17th. Finally, Wolfe Research assumed coverage on shares of Stevanato Group in a research note on Tuesday, June 2nd. They issued an “outperform” rating and a $21.00 price target on the stock. Two research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, Stevanato Group has an average rating of “Buy”.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.